CENTURION BIOPHARMA CORP has a total of 26 patent applications. Its first patent ever was published in 2016. It filed its patents most often in Australia, Canada and Israel. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are NAUREX INC, NEUREN PHARMACEUTICALS LTD and ZHANG XITIAN.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 4 | |
#2 | Canada | 3 | |
#3 | Israel | 3 | |
#4 | Republic of Korea | 3 | |
#5 | WIPO (World Intellectual Property Organization) | 3 | |
#6 | Brazil | 2 | |
#7 | China | 2 | |
#8 | EPO (European Patent Office) | 2 | |
#9 | United States | 2 | |
#10 | Hong Kong | 1 | |
#11 | Japan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides | |
#4 | Heterocyclic compounds | |
#5 | Special acyclic compounds | |
#6 | Sugars | |
#7 | Organic chemistry methods |
# | Name | Total Patents |
---|---|---|
#1 | Kratz Felix | 20 |
#2 | Koester Stephan David | 20 |
#3 | Garcia Fernandez Javier | 20 |
#4 | Nollmann Friederike I | 20 |
#5 | Abu Ajaj Khalid | 20 |
#6 | Pes Lara | 18 |
#7 | Warnecke Anna | 18 |
#8 | Magnusson Johannes Pall | 18 |
#9 | Medda Federico | 18 |
#10 | Perez Galan Patricia | 18 |
Publication | Filing date | Title |
---|---|---|
AU2019309242A1 | Imaging agents for radiolabeling exogenous and endogenous albumin | |
KR20200118408A | Albumin-binding prodrugs of auristatin E derivatives | |
WO2019108975A1 | Maytansinoid-based drug delivery systems |